Fortress Biotech
FBIO
49 hedge funds and large institutions have $11.9M invested in Fortress Biotech in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 14 closing their positions.
84% more capital invested
Capital invested by funds: $6.44M → $11.9M (+$5.44M)
0.13% less ownership
Funds ownership: 0.84% → 0.71% (-0.13%)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
20% less funds holding
Funds holding: 61 → 49 (-12)
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $25K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$329K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$206K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$101K |
| 4 |
CL
CPWM LLC
Seattle,
Washington
|
+$35K |
| 5 |
DY
Dowling & Yahnke
San Diego,
California
|
+$35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$306K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$282K |
| 3 |
SO
STRS Ohio
Columbus,
Ohio
|
-$188K |
| 4 |
Renaissance Technologies
New York
|
-$140K |
| 5 |
Morgan Stanley
New York
|
-$107K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OAM
51
Oxford Asset Management
Oxford,
United Kingdom
| – | -$38K | -2,911 | Closed |
|
52
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$28K | -2,184 | Closed |
|
53
Two Sigma Investments
New York
| – | -$27K | -2,064 | Closed |
|
54
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$29.8K | -1,137 | Closed |
|
55
Invesco
Atlanta,
Georgia
| – | -$12K | -930 | Closed |
|
56
Citadel Advisors
Miami,
Florida
| – | -$11K | -860 | Closed |
|
|
ARTA
57
A.R.T. Advisors
New York
| – | -$11K | -822 | Closed |
|
58
AllianceBernstein
Nashville,
Tennessee
| – | -$10K | -767 | Closed |
|
|
DAM
59
Delta Asset Management
Memphis,
Tennessee
| – | -$5K | -400 | Closed |
|
|
TJHA
60
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
| – | -$2K | -172 | Closed |
|
61
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$760 | -29 | -83% |
|
FBIO Hedge Fund Activity: Q1 2019 in Review
49 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2019, worth a combined $11.9M — up 84% from $6.44M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of FBIO and 3 opened new positions — a net loss of 11 holders — while 15 trimmed existing stakes and 13 added.
The largest buyer was Vanguard Group, adding an estimated $329K. The largest seller was Jacobs Levy Equity Management, cutting an estimated $306K.
- 49 institutional investors held Fortress Biotech (FBIO) as of Q1 2019, down from 61 in Q4 2018.
- Funds reported $11.9M of Fortress Biotech stock for Q1 2019, up 84% quarter-over-quarter.
- 3 funds opened new Fortress Biotech positions in Q1 2019 and 14 closed out, a net change of -11 holders.
- The largest Fortress Biotech buyer in Q1 2019 was Vanguard Group, an estimated $329K added.
- The largest Fortress Biotech seller in Q1 2019 was Jacobs Levy Equity Management, an estimated $306K sold.
Based on aggregated 13F filings for Q1 2019.